...
首页> 外文期刊>Journal of thrombosis and thrombolysis >Genetic polymorphisms in platelet-related proteins and coronary artery disease: investigation of candidate genes, including N-acetylgalactosaminyltransferase 4 (GALNT4) and sulphotransferase 1A1/2 (SULT1A1/2).
【24h】

Genetic polymorphisms in platelet-related proteins and coronary artery disease: investigation of candidate genes, including N-acetylgalactosaminyltransferase 4 (GALNT4) and sulphotransferase 1A1/2 (SULT1A1/2).

机译:血小板相关蛋白和冠状动脉疾病的遗传多态性:研究候选基因,包括N-乙酰半乳糖胺基转移酶4(GALNT4)和磺基转移酶1A1 / 2(SULT1A1 / 2)。

获取原文
获取原文并翻译 | 示例
           

摘要

BACKGROUND: Both platelet function and heart disease show strong genetic components, many of which remain to be elucidated. MATERIALS AND METHODS: The roles of candidate polymorphisms in ten platelet-associated genes were compared between 1,237 Acute Coronary Syndrome (ACS) cases (with myocardial infarction and unstable angina) and 386 controls, from an Irish Caucasian population. Additionally, 361 stable angina patients were investigated. Two genes of interest were followed up in a separate Irish study of 1,484 individuals (577 with IHD and 907 unaffected). RESULTS: The GALNT4 (N-acetyl galactosaminyl transferase 4) 506I allele was significantly underrepresented in ACS (OR = 0.66, CI = 0.52-0.84; P = 0.001; P = 0.01 after correction for multiple testing), while the SULT1A1 (Sulphotransferase 1A1) 213H allele was associated with risk of ACS (OR = 1.37, CI = 1.08-1.74; P = 0.01; P = 0.1 after correction for multiple testing). Subsequent genotyping of further SNPs in GALNT4 in the family-based (IHD) group revealed that the 506I allele showed the same trend towards protecting against ACS but the haplotypic test over the four commonest haplotypes was not significant (P = 0.55). In contrast, the SULT1A1/SULT1A2 gene complex showed suggestive haplotypic association in the family-based study (P = 0.07), with the greatest increase in risk conferred by the SULT1A2 235T allele (P = 0.025). CONCLUSION: We have identified two risk genes for cardiovascular disease, one of whose (GALNT4) effects may be on either platelet or endothelial function through modifications of PSGL1 or other important glycosylated proteins. The role of sulphotransferases (SULT1A1/2) in cardiovascular disease requires further exploration. Further validation of cardiovascular risks conferred by both genes in other populations (including gene copy number variation) is warranted.
机译:背景:血小板功能和心脏病均显示出强大的遗传成分,其中许多仍有待阐明。材料与方法:比较了爱尔兰高加索人人群的1,237例急性冠脉综合征(ACS)(患有心肌梗塞和不稳定型心绞痛)病例和386例对照的10个血小板相关基因中候选多态性的作用。另外,对361名稳定型心绞痛患者进行了研究。在一项针对1,484名个体的爱尔兰研究(其中有577名患有IHD和907名未受影响)中,对两个感兴趣的基因进行了追踪。结果:GALNT4(N-乙酰半乳糖胺基转移酶4)506I等位基因在ACS中的代表性明显偏低(OR = 0.66,CI = 0.52-0.84; P = 0.001;经过多次测试校正后的P = 0.01),而SULT1A1(Sulphotransferase 1A1) )213H等位基因与ACS风险相关(OR = 1.37,CI = 1.08-1.74; P = 0.01;经过多次测试校正后P = 0.1)。基于家族的(IHD)组中GALNT4中其他SNP的随后基因分型显示,506I等位基因显示出抗ACS的相同趋势,但对四种最常见单倍型的单倍型检测并不显着(P = 0.55)。相反,在基于家庭的研究中,SULT1A1 / SULT1A2基因复合体显示出提示的单倍型关联(P = 0.07),而SULT1A2 235T等位基因赋予的风险增加最大(P = 0.025)。结论:我们确定了两个心血管疾病的风险基因,其中一个基因(GALNT4)可能通过修饰PSGL1或其他重要的糖基化蛋白而影响血小板或内皮功能。磺基转移酶(SULT1A1 / 2)在心血管疾病中的作用需要进一步探索。有必要进一步验证其他人群中两个基因赋予的心血管风险(包括基因拷贝数变异)。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号